AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NewEdge Advisors, LLC | 1,300 | $13,390 | 0.00% |
RHUMBLINE ADVISERS | 1,256 | $12,936 | 0.00% |
UBS Group AG | 11,434 | $117,771 | 0.00% |
CITIGROUP INC | 2,630 | $27,089 | 0.00% |
SALEM INVESTMENT COUNSELORS INC | 450 | $4,635 | 0.00% |
JANE STREET GROUP, LLC | 21,680 | $223,304 | 0.00% |
MORGAN STANLEY | 437,056 | $4,501,683 | 0.00% |
BALDWIN BROTHERS LLC/MA | 500 | $5,150 | 0.00% |
WOLVERINE TRADING, LLC | 33,400 | $344,020 | 0.00% |
WOLVERINE TRADING, LLC | 15,300 | $157,590 | 0.00% |
WOLVERINE TRADING, LLC | 14,792 | $152,358 | 0.00% |
External links
This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q3 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.